Mandalay Bay South Convention Center in Las Vegas

• “Efficacy and Safety of the MC4R Agonist Setmelanotide in POMC Deficiency Obesity: A Phase 3 Trial,” presented by Peter Kühnen, M.D., Institute for Experimental Pediatric Endocrinology, Charité Universitätsmedizin Berlin, Germany
      Nov. 4 oral presentation slides
      Nov. 7 poster presentation

• “Efficacy and Safety of the MC4R Agonist Setmelanotide in LEPR Deficiency Obesity: A Phase 3 Trial,” oral presentation by Erica Van Den Akker, M.D., Ph.D., Erasmus MC-Sophia Children’s Hospital University in Rotterdam, Netherlands
      Nov. 4 oral presentation slides
      Nov. 7 poster presentation

• "Functional Characterization of Missense Variants in LEPR, POMC, & PCSK1 Genes Arising From SNV,” poster presentation Nov. 5.